Firm at a glance
GPV (GreatPoint Ventures) is a platform private equity firm, per its own website [S1].
What they buy
GPV appears to concentrate on technology-enabled businesses across healthcare, data infrastructure, and emerging technology sectors [S2]. The firm’s portfolio demonstrates a pattern of investing in companies applying software, artificial intelligence, and biotechnology to solve problems in healthcare delivery, data management, and food systems. Public records show approximately 40 portfolio companies spanning healthcare technology, biotechnology, data technology, and food technology as of January 2025 [S2].
Portfolio
Healthcare Technology
Abett, Activ Surgical, Anagram, Atlas Health, Carenostics, Endear Health, InsightRX, and Integral [S2].
Healthcare Services
Carrum Health and Devoted Health [S2].
Biotechnology
Arbor BioTechnologies, CellFE, Diffuse Bio, Excision Bio, Glympse Bio, and Guide Therapeutics [S2].
Data Technology
Coalesce, Coherent, Datalogz, Definity, e6data, Featureform, and Kinetica [S2].
Food Technology
Beyond Meat, Current Foods, Farmer’s Fridge, Good PLANeT Foods, and Hero [S2].
Enterprise Software
BeyondCore, Hypori, and Inkeep [S2].
Other Technology Sectors
Datapeople (HR Technology), Even Financial (Financial Technology), Cooler Screens and Extend (Retail Technology), BookOutdoors (Consumer Technology), Call Hyper (Public Safety Technology), Harmonic (Artificial Intelligence), K2 (Cybersecurity), and KlearNow (Logistics Technology) [S2].
Recent activity (last 24 months)
* Qualified Health fund close, March 2026 [S3]
* Seraphic exit, January 2026 [S3]
* RapidDeploy exit, February 2025 [S3]
* Seraphic Security fund close, January 2025 [S3]
* Sirona Medical fund close, November 2024 [S3]
* Harmonic fund close, September 2024 [S3]
* Recogni fund close, February 2024 [S3]
How this firm fits a seller
GPV appears oriented toward growth-stage technology companies rather than traditional owner-operator businesses, based on the portfolio composition of venture-backed software and biotech companies [S2]. The firm’s recent activity shows continued investment through 2026, with both new fund closes and portfolio exits [S3]. Sellers in healthcare technology, data infrastructure, or food technology sectors may find alignment with GPV’s observed investment themes. The firm’s exit activity in 2025 and 2026 suggests active portfolio management and liquidity generation for portfolio companies [S3].
Sources
[S1] https://www.gpv.com (as of 2025-01-17)
[S2] https://www.gpv.com/companies (as of 2025-01-17)
[S3] https://www.gpv.com/newsroom (as of 2025-01-17)
Frequently asked questions
Does GreatPoint Ventures buy Healthcare Technology businesses?
Yes, healthcare technology represents a significant portion of GPV’s portfolio, with at least eight healthcare technology companies publicly listed including Abett, Activ Surgical, Anagram, Atlas Health, Carenostics, Endear Health, InsightRX, and Integral [S2]. Recent activity includes a fund close for Sirona Medical in November 2024 [S3].
What companies has GreatPoint Ventures acquired recently?
Recent fund closes reported by GPV include Qualified Health (March 2026), Seraphic Security (January 2025), Sirona Medical (November 2024), and Harmonic (September 2024) [S3]. The firm also completed exits of Seraphic in January 2026 and RapidDeploy in February 2025 [S3].
Where is GreatPoint Ventures based and how big is the firm?
GPV operates as a platform private equity firm per its website [S1], though specific headquarters location and fund size information were not surfaced in publicly available materials as of January 2025. The firm maintains a portfolio of approximately 40 companies across technology sectors [S2].
Is GreatPoint Ventures still actively acquiring?
Yes, GPV appears actively investing based on recent fund closes in March 2026 (Qualified Health), January 2025 (Seraphic Security), November 2024 (Sirona Medical), and September 2024 (Harmonic) [S3]. This activity suggests ongoing deployment of capital through early 2026.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.